Atlas Trials

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine

Clinical trial NCT01005238 · TERMINATED

Trial details

NCT number
NCT01005238
Sponsor
University Hospital, Basel, Switzerland
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis, Chronic
Start date
2009-09-01
Primary completion
2014-12-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.